Glucose control guidelines: Current concepts

Clinical Nutrition

Volumn 17, Issue SUPPL. 2, 1998, Pages 7-17

  Barranco, J Gonzáles ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES CONTROL; DIET; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; REVIEW;

ALGORITHMS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; EXERCISE; GUIDELINES; HUMANS; HYPOGLYCEMIC AGENTS; RISK FACTORS;

EID: 0031727460     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0261-5614(98)80013-7     Document Type: Article

References (21)

1. National Diabetes Data Group. Position Statement: Office guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care 1993; 16: 4
2. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057
3. Kirk J K. The risk of hyperglycemic, hyperosmolar nonketotic coma (HHNK) in elderly patients with diabetes. Diabetes Spectrum 1993; 6: 324-325
4. Sabo C E, Michael S R. Managing DKA and preventing a recurrence. Nursing 1989; 2: 50-56
5. American Diabetes Association. Costs of diabetes. Diabetes 1996 Vital Statistics. Alexandria, VA: American Diabetes Association 1996: 67-69
6. Low PA. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Intl Rev Neurobiol 1989; 33: 355-438
7. Dyck J. Kratz K M, Karnes J L. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824
8. Nathan D M, Singer D E, Godine J E, Perlmuter L C. Noninsulin-dependent diabetes in older patients: complications and risk factors. Am J Med 1986; 81: 837-842
9. Krolewski A S, Warram J H, Rand L I et al. Risk of proliferative diabetic retinopathy in juvenile onset type 1 diabetes: a 40-year follow-up study. Diabetes Care 1986; 9: 443-452
10. Nathan D M. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676-1685
11. American Diabetes Association. Diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1996; 19: S103-S106
12. Colwell J A. DCCT findings, applicability and implications for NIDDM. Diabetes Rev 1994; 2: 277-291
13. Howard B V, Howard W J. Dyslipidemia in noninsulin-dependent diabetes mellitus. Endocr Rev 1994; 154: 263-274
14. Laasko M, Ronnemaa T, Ryorala K et al. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988; 11: 449-463
15. Krolewski A S, Kosinski E J, Warram J H et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59: 750-755
16. Peterson K A, Smith C D. The DCCT findings and standards of care for diabetes. Am Fam Physician 1995; 52(4): 1092-1098
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
18. Wang P H, Lau J, Chalmers T C. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 1993; 341: 1306-1309
19. Lasker R. The diabetes control and complications trial: implications for policy and practice (editorial). N Engl J Med 1993: 1035-1036
20. Libman I, Songer T, LaPorte R. How many people in the US have IDDM? Diabetes Care 1993; 16(5): 841-842
21. Abraira C, Colwell J A, Nuttal F Q et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VACSDM). Diabetes Care 1995; 18: 1113-1123